| Features: Therapy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Whole Body Vibration (WBV) is a mechanical intervention in which individuals stand or exercise on a vibrating platform, producing oscillatory mechanical stimuli that activate neuromuscular, endocrine, and circulatory responses. In oncology contexts, WBV is not a direct cytotoxic therapy. Its relevance lies primarily in supportive care, including preservation of muscle mass, mitigation of cancer-related fatigue, improvement of bone density, enhancement of circulation, and modulation of inflammatory signaling. Preclinical mechanobiology research suggests mechanical stimuli can influence bone remodeling (RANKL/OPG axis), myokine release (e.g., IL-6 in exercise context), and possibly immune tone. However, WBV should be categorized as a supportive or rehabilitation modality rather than a tumor-targeting intervention. Clinical evidence in cancer patients primarily addresses quality of life, sarcopenia, and functional performance.Cancer Pathway Table: Whole Body Vibration
TSF: P = immediate neuromuscular activation; R = systemic signaling shifts; G = long-term musculoskeletal and functional adaptation. AD Summary — Whole Body Vibration (WBV)Whole Body Vibration (WBV) is a mechanical intervention that delivers low-amplitude, oscillatory stimuli through a vibrating platform, activating neuromuscular and neurovascular pathways. In Alzheimer’s disease (AD) research, WBV is explored as a non-pharmacologic intervention aimed at improving cerebral blood flow, reducing neuroinflammation, enhancing neurotrophic signaling (e.g., BDNF), and mitigating sarcopenia-related frailty that contributes to cognitive decline. Preclinical studies suggest WBV may reduce microglial activation, lower pro-inflammatory cytokines, and support hippocampal plasticity. Clinical data in AD populations are still limited but suggest potential benefits for balance, mobility, and possibly cognitive performance. WBV should be positioned as a supportive neurorehabilitative modality rather than a direct disease-modifying therapy.Alzheimer’s Disease Table: Whole Body Vibration
TSF: P = immediate vascular activation; R = inflammatory and signaling shifts; G = long-term neuroplastic and functional adaptations. |
| Source: HalifaxProj(inhibit) |
| Type: |
| Cyclooxygenase-2 (COX-2) is an enzyme that plays a critical role in the conversion of arachidonic acid to prostaglandins, which are lipid compounds involved in various physiological processes, including inflammation, pain, and fever. COX-2 is an inducible enzyme, meaning its expression is typically low in normal tissues but can be upregulated in response to inflammatory stimuli, growth factors, and certain oncogenic signals. -Cyclooxygenase-2 (COX-2), the rate-limiting enzyme in prostaglandin biosynthesis, plays a key role in inflammation and circulatory homeostasis. -COX-2 is an inducible enzyme that is upregulated in response to pro-inflammatory signals, including cytokines (e.g., IL-1β, TNF-α) and growth factors. COX-2 is often overexpressed in various tumors, including colorectal, breast, lung, and prostate cancers. The prostaglandins produced by COX-2, particularly prostaglandin E2 (PGE2), have several effects that can facilitate cancer progression: Cell Proliferation: PGE2 can promote the proliferation of cancer cells by activating signaling pathways such as the PI3K/Akt and MAPK pathways. Nonselective NSAIDs, such as aspirin and ibuprofen, inhibit both COX-1 and COX-2. Epidemiological studies have suggested that regular use of NSAIDs may reduce the risk of certain cancers, particularly colorectal cancer. Drugs specifically targeting COX-2, such as celecoxib, have been developed. COX-2 and xanthine oxidase are ROS-producing pro-oxidant enzymes that contribute to inflammation. Elevated COX‑2 levels, often found in inflammatory conditions or certain types of cancers, can contribute to increased production of ROS. |
| 1755- | WBV, | Reduction of breast cancer extravasation via vibration activated osteocyte regulation |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:176 Target#:66 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid